Ultralife Corporation
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.9% | +3.9% | +14.7% | +23.6% | +20.4% | -4.7% | +15.9% | +5.6% | +5.8% | +23.7% | -1.6% | |
| – | -8.6% | -4.7% | +25.0% | +8.6% | +4.7% | -8.4% | +3.1% | +18.7% | +14.2% | +7.7% | +8.9% | |
| – | -18.7% | -26.3% | +71.2% | +41.5% | -71.4% | +43.9% | -21.0% | -32.1% | +79.9% | -33.3% | +36.3% | |
| – | -18.7% | -26.3% | +71.2% | +41.5% | -71.4% | +43.9% | -21.0% | -32.1% | +79.9% | -33.3% | +36.3% | |
| – | +1.1% | +13.5% | +11.2% | +9.3% | +88.0% | -30.1% | -3.9% | +37.3% | +14.3% | -7.5% | +15.6% | |
| – | -8.7% | -1.5% | +12.2% | -13.2% | +30.3% | -5.3% | +17.7% | +24.1% | +2.5% | +21.7% | +5.1% | |
| – | -7.9% | -11.5% | -5.4% | +41.9% | +109.7% | +1.4% | +4.9% | -9.4% | – | – | – | |
| – | -0.8% | +22.6% | +2.5% | -1.7% | +33.0% | +1.0% | +40.9% | -1.7% | +0.4% | +19.8% | +0.8% | |
| – | -9.0% | +82.3% | -1.5% | -8.2% | +49.5% | -5.3% | +88.8% | -8.4% | -5.1% | +62.6% | -55.5% | |
| – | -1.3% | +8.9% | +7.4% | -14.2% | +123.6% | -40.3% | +101.2% | +24.5% | +1.6% | +63.2% | +0.6% | |
| – | -3.0% | +4.3% | +25.7% | +5.0% | +15.0% | +8.8% | +1.2% | +52.8% | -17.9% | +23.4% | +27.5% | |
| – | – | – | – | – | +353.8% | +2.5% | +40.5% | +1.0% | 0.0% | +34.3% | +6.1% | |
| – | -7.2% | +12.3% | +20.5% | +12.9% | -5.4% | +15.5% | -9.4% | +63.6% | -29.5% | +24.9% | +23.0% | |
| – | – | – | – | – | – | – | – | +2.4% | +22.3% | +118.0% | -11.6% | |
| – | -8.1% | +2.8% | +16.4% | +32.1% | +4.9% | +6.4% | +0.7% | -1.1% | +7.8% | +6.9% | -3.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -6.0% | -6.2% | +2.9% | +3.1% | -1.0% | -0.5% | -0.4% | +0.5% | +0.6% | +3.3% | -0.7% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.